Zobrazeno 1 - 10
of 32
pro vyhledávání: '"S. K. Chambers"'
Publikováno v:
International Journal of Gynecologic Cancer. 13:216-222
A pilot study investigated topotecan (Hycamtin, GlaxoSmithKline, Philadelphia, PA), a topoisomerase I inhibitor, in treating uterine serous carcinoma, a typically unresponsive aggressive tumor. Fifteen patients were surgically staged, then treated wi
Autor:
S K, Chambers, M K, Hyde
Publikováno v:
European journal of cancer care. 24(1)
Publikováno v:
European journal of cancer care. 22(6)
The burden of cancer in China is increasing with future psycho-oncological interventions crucial. A systematic review of psycho-oncology research in China was undertaken to assess quantity, design and target trends over time. Medline, PsycINFO, CINAH
Publikováno v:
Psycho-oncology. 22(11)
To examine prevalence and predictors of cancer-specific distress in undiagnosed men with and without a family history of prostate cancer, and to examine the contribution of perceptions of an affected relative's cancer experience on the distress of un
Publikováno v:
European journal of cancer care. 21(2)
Cancer information services are a highly accessible source of support for people affected by cancer. To date the nature and extent of distress experienced by such callers and their unmet support needs have not been well described. A cross-sectional s
Autor:
S K, Chambers
Publikováno v:
Methods in molecular medicine. 39
Epithelial ovarian cancer cells spread by two major pathways. One is by exfoliation of tumor cells from the ovarian surface, with resulting implants on peritoneal surfaces such as omentum, diaphragm, and bowel serosa. The second pathway of spread of
Publikováno v:
Neoplasma. 58(2)
The exact role of follicle-stimulating hormone (FSH) and luteinizing hormone (LH) in ovarian epithelial carcinoma (OEC) development has not been yet characterized. This prompted us to identify particular proteins to better understand the underlying m
Autor:
S. K. Chambers, L. M. Hess
Publikováno v:
Fundamentals of Cancer Prevention ISBN: 9783540689850
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6d7f3db6a54a213632584aca4e91a5ff
https://doi.org/10.1007/978-3-540-68986-7_17
https://doi.org/10.1007/978-3-540-68986-7_17
Publikováno v:
International journal of cancer. 79(5)
High levels of plasminogen activator inhibitor-1 (PAI-1) in tissue extracts have been associated with poor prognosis in many epithelial cancers. Ovarian cancers contain a higher concentration of PAI-1 than benign ovarian tumors or normal ovaries. Rep
Autor:
S K, Chambers
Publikováno v:
Surgical oncology clinics of North America. 7(2)
Research in gynecologic oncology has been increasingly emphasized over the last decade. The formal training within this subspecialty has expanded to include quality research, both clinical and laboratory science, as an integral part. There have also